BBD vs JPM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Banco Bradesco (BBD) exhibits a weak financial health profile with a Piotroski F-Score of just 2/9, indicating significant fundamental deterioration. Despite this, the stock appears attractively valued with a P/E of 10.68 (below sector average of 21.15) and trades below its Graham Number of $5.11, while offering a high dividend yield of 5.47%. Earnings growth is strong year-over-year (+37.5%), but revenue growth is minimal (0.80% YoY), and technical indicators suggest weakening momentum (Technical Trend: 10/100). Analysts recommend a 'buy' with a target price below current market price, creating a conflicting signal that warrants caution.
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Compare Another Pair
Related Comparisons
BBD vs JPM: Head-to-Head Comparison
This page compares Banco Bradesco S.A. (BBD) and JPMorgan Chase & Co. (JPM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.